Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 36

1.

Post-transplant lymphoproliferative disorders after heart or kidney transplantation at a single centre: presentation and response to treatment.

Aversa SM, Stragliotto S, Marino D, Calabrese F, Rigotti P, Marchini F, Gambino A, Feltrin G, Boso C, Canova F, Soldà C, Mazzarotto R, Burra P.

Acta Haematol. 2008;120(1):36-46. doi: 10.1159/000155234. Epub 2008 Sep 16.

PMID:
18797163
[PubMed - indexed for MEDLINE]
2.

Low-dose chemotherapy for children with post-transplant lymphoproliferative disease.

Gross TG.

Recent Results Cancer Res. 2002;159:96-103. Review.

PMID:
11785850
[PubMed - indexed for MEDLINE]
3.

Posttransplantation lymphoproliferative disorder in kidney and heart transplant recipients receiving thymoglobulin: a systematic review.

Marks WH, Ilsley JN, Dharnidharka VR.

Transplant Proc. 2011 Jun;43(5):1395-404. doi: 10.1016/j.transproceed.2011.03.036. Review.

PMID:
21693205
[PubMed - indexed for MEDLINE]
4.

[Cancer after kidney transplantation].

Sandrini S, Setti G, Bossini N, Maiorca P.

G Ital Nefrol. 2004 Jan-Feb;21 Suppl 26:S67-73. Review. Italian.

PMID:
15732048
[PubMed - indexed for MEDLINE]
5.

Post-transplant lymphoproliferative disorders of oral cavity.

Ojha J, Islam N, Cohen DM, Marshal D, Reavis MR, Bhattacharyya I.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008 May;105(5):589-96. doi: 10.1016/j.tripleo.2007.11.028. Review.

PMID:
18442744
[PubMed - indexed for MEDLINE]
6.

Post-transplantation lymphoproliferative disorder (PTLD) twenty years after heart transplantation: a case report and review of the literature.

Grivas PD.

Med Oncol. 2011 Sep;28(3):829-34. doi: 10.1007/s12032-010-9523-2. Review.

PMID:
20390467
[PubMed - indexed for MEDLINE]
7.

Post-transplant lymphoproliferative disorder--the potential of proliferation signal inhibitors.

Pascual J.

Nephrol Dial Transplant. 2007 May;22 Suppl 1:i27-35. Review.

PMID:
17456616
[PubMed - indexed for MEDLINE]
Free Article
8.

Role of chemotherapy and rituximab for treatment of posttransplant lymphoproliferative disorder in solid organ transplantation.

Lee JJ, Lam MS, Rosenberg A.

Ann Pharmacother. 2007 Oct;41(10):1648-59. Epub 2007 Sep 11. Review.

PMID:
17848421
[PubMed - indexed for MEDLINE]
9.

Posttransplant lymphoproliferative disorder.

Everly MJ, Bloom RD, Tsai DE, Trofe J.

Ann Pharmacother. 2007 Nov;41(11):1850-8. Epub 2007 Oct 16. Review. Erratum in: Ann Pharmacother. 2007 Dec;41(12):2074.

PMID:
17940127
[PubMed - indexed for MEDLINE]
10.

Management of patients with post-transplant lymphoproliferative disorder: the role of rituximab.

Svoboda J, Kotloff R, Tsai DE.

Transpl Int. 2006 Apr;19(4):259-69. Review.

PMID:
16573540
[PubMed - indexed for MEDLINE]
11.

Resolution of oral non-Hodgkin's lymphoma by reduction of immunosuppressive therapy in a renal allograft recipient: a case report and review of the literature.

Keogh PV, Fisher V, Flint SR.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002 Dec;94(6):697-701. Review.

PMID:
12464893
[PubMed - indexed for MEDLINE]
12.

Post-transplant multiple myeloma in a pediatric renal transplant patient.

Tcheng WY, Said J, Hall T, Al-Akash S, Malogolowkin M, Feig SA.

Pediatr Blood Cancer. 2006 Aug;47(2):218-23. Review.

PMID:
16086426
[PubMed - indexed for MEDLINE]
13.

Malignancy in pediatric transplant recipients.

Buell JF, Gross TG, Thomas MJ, Neff G, Muthiah C, Alloway R, Ryckman FC, Tiao GM, Woodle ES.

Semin Pediatr Surg. 2006 Aug;15(3):179-87. Review.

PMID:
16818139
[PubMed - indexed for MEDLINE]
14.

Post-transplantation lymphoproliferative disorder: the spectrum of imaging appearances.

Scarsbrook AF, Warakaulle DR, Dattani M, Traill Z.

Clin Radiol. 2005 Jan;60(1):47-55. Review.

PMID:
15642292
[PubMed - indexed for MEDLINE]
15.

Update on pediatric heart transplantation. Long-term complications.

Gajarski RJ, Kearney DL, Price JK, Denfield SW.

Tex Heart Inst J. 1997;24(4):260-8. Review.

PMID:
9456478
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

[Remission induced by dose-reduction of immunosuppressants alone in a patient with post-transplant lymphoproliferative disorder of central nervous system origin].

Minauchi K, Koizumi K, Kondo M, Takigami M, Harada H, Fujita H, Mukai M.

Rinsho Ketsueki. 2011 May;52(5):272-7. Review. Japanese.

PMID:
21646772
[PubMed - indexed for MEDLINE]
17.

Post-transplant hepatosplenic T-cell lymphoma successfully treated with HyperCVAD regimen.

Tey SK, Marlton PV, Hawley CM, Norris D, Gill DS.

Am J Hematol. 2008 Apr;83(4):330-3. Review.

PMID:
17876769
[PubMed - indexed for MEDLINE]
18.

Urological malignancy after renal transplantation.

Besarani D, Cranston D.

BJU Int. 2007 Sep;100(3):502-5. Review.

PMID:
17669141
[PubMed - indexed for MEDLINE]
19.

Posttransplant lymphoproliferative disorder: a pictorial review.

Burney K, Bradley M, Buckley A, Lyburn I, Rye A, Hopkins R.

Australas Radiol. 2006 Oct;50(5):412-8. Review.

PMID:
16981935
[PubMed - indexed for MEDLINE]
20.

Pediatric post-transplant lymphoproliferative disorder after cardiac transplantation.

Ohta H, Fukushima N, Ozono K.

Int J Hematol. 2009 Sep;90(2):127-36. doi: 10.1007/s12185-009-0399-x. Epub 2009 Aug 12. Review.

PMID:
19669857
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk